Andorra
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Andorra (AD)
| 2011 | 4.8 thousand |
| 2024 | 7.9 thousand |
| 2050 | 9.6 thousand |
Andorra is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Portugal and Spain.
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | 4.8 | 7.9 | 9.6 |
| Age-standardised prevalence of diabetes, % | - | 5.4 | 10.1 | 11.8 |
| Proportion of people with undiagnosed diabetes, % | - | - | 28.5 | - |
| People with undiagnosed diabetes, in 1,000s | - | 1.7 | 2.3 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 4.0 | 4.3 |
| Age-standardised prevalence of IFG, % | - | - | 5.5 | 6.0 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 6.0 | 6.9 | 7.8 |
| Age-standardised prevalence of IGT, % | - | 7.5 | 9.5 | 10.5 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 34.0 | 43.5 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 20.2 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 24.9 | 23.1 |
| Total diabetes-related health expenditure, ID million | - | - | 31.9 | 29.6 |
| Diabetes-related health expenditure per person, USD | - | 3,910.0 | 3,138.9 | 2,410.8 |
| Diabetes-related health expenditure per person, ID | - | - | 4,012.3 | 3,081.6 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | - | - |
| People with type 1 diabetes (0-19 y) | - | - | - | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | 64.5 | 63.4 | 58.6 |
| Population of children and adolescents (0-19 y) | - | - | - | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
